Rafferty Asset Management, LLC Myriad Genetics Inc Transaction History
Rafferty Asset Management, LLC
- $29.4 Billion
- Q2 2025
A detailed history of Rafferty Asset Management, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 112,948 shares of MYGN stock, worth $892,289. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,948
Previous 146,804
23.06%
Holding current value
$892,289
Previous $1.3 Million
53.99%
% of portfolio
0.0%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding MYGN
# of Institutions
235Shares Held
95.3MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$73.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$38.9 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$38 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$36.2 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $637M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...